Breaking News: Large Study Shows Measuring Medication Risk with MedWise® Can Help Reduce Premature Death
Click to learn what these findings mean for medication safety and practice

Sweilem B. Al Rihani, PharmD, PhD

Sweilem B. Al Rihani, PharmD, PhD
Clinical Research Scientist

Sweilem B. Al Rihani, PharmD, PhD is a clinical research scientist at TRHC’s Precision Pharmacotherapy R&D Institute. He received his PharmD from the University of Jordan in 2012 and his PhD in pharmacy from Auburn University-Alabama in 2019. Dr. Al Rihani joined TRHC in 2019 with three years of experience as a clinical pharmacist.

Dr. Al Rihani has always been interested in drug discovery focusing mainly on managing challenging diseases. During his PhD, Dr. Al Rihani focused on the blood brain barrier integrity as a potential therapeutic target for Alzheimer’s disease and related disorders.

Dr. Al Rihani is the humble recipient of the 2017 Alzheimer’s Drug Discovery Foundation (ADDF) Young investigator scholarship, 2018 Rho Chi Pharmacy Honor Society Award, 2019 Center for Neuroscience initiative Graduate Research Award, 2019 Outstanding International Graduate Student Award, and honorable recipient of 2019 Auburn University Graduate School Student Marshal Award.